MENU
MENU
About
Overview
History
Corporate Offices
Technology & IP
Corporate
Board & Management
Advisory Board
Corporate Governance
Notice of Meetings
Investors
News & Media
ASX Announcements
Presentations
Stock Information
Company Reports
CEO Reports
Investor Relations
Capital Raising
Group Companies
ATCOR
CONNEQT
Blog
Contact us
✕
Receives FDA Clearance
LEARN MORE
play_arrow
Improving Patient Outcomes
using digital vascular biomarkers
LEARN MORE
play_arrow
• Initiate novel protocol endpoints
• Enhance patient diversity enrollment
• Establish patient and population baseline
• Reduce adverse events
• Improve patient engagement
• Assess dosing level
CardieX companies specialize in the development of biomarkers and digital solutions for large-scale vascular health disorders
LEARN MORE
CEO REPORTS
LEARN MORE
LATEST INVESTMENT NEWS
LEARN MORE
TECHNOLOGY & PATENTS
LEARN MORE
LEARN MORE
FDA Grants 510(k) Clearance for the CONNEQT Pulse, a World-First Vascular Biometric Health Monitor
CLICK TO READ MORE
CONNEQT Pulse Selected as CES 2023 Innovation Award Honoree
CLICK TO READ MORE
Hypertension & ATCOR Central Blood Pressure Measurement
CLICK TO VIEW VIDEO
A New Paradigm in Hypertension Care from ATCOR
CLICK TO VIEW VIDEO
FOCUS ON
Three things women should know about their heart health
LEARN MORE
New Approaches to Managing Hypertension Using Central Blood Pressure Measurement and Supplements
LEARN MORE
RECENT ARTICLES
April 25, 2024
CONNEQT Pulse Achieves Milestone with Inclusion on the Validated Device List
Read more
February 9, 2024
In Memoriam: Remembering Professor Michael O’Rourke, a Visionary in Cardiovascular Health
Read more
March 18, 2020
Can Central Blood Pressure Predict Alzheimer’s and Dementia?
Read more
SEE ALL ARTICLES
CLINICAL TRIAL AND RESEARCH PARTNERS